ARHGAP24
Basic information
Region (hg38): 4:85475150-86002668
Links
Phenotypes
GenCC
Source:
- familial idiopathic steroid-resistant nephrotic syndrome (Supportive), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARHGAP24 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 25 | 30 | ||||
missense | 79 | 92 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 4 | 7 | ||
non coding | 23 | 37 | 61 | |||
Total | 0 | 0 | 82 | 57 | 46 |
Variants in ARHGAP24
This is a list of pathogenic ClinVar variants found in the ARHGAP24 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-85570281-T-C | Benign (Nov 11, 2018) | |||
4-85570317-C-CTCTT | Likely benign (Sep 19, 2021) | |||
4-85570360-CTTTCTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTT-C | Likely benign (May 25, 2021) | |||
4-85570364-CTCTTTCTTTCTTTCTTTCTTTCTTTCTT-C | Benign (Jul 24, 2020) | |||
4-85570364-CTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTT-C | Benign (Jun 18, 2020) | |||
4-85570364-CTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTT-C | Likely benign (May 22, 2021) | |||
4-85570386-CTTT-C | Benign (Mar 15, 2020) | |||
4-85570431-C-CT | Benign (Dec 24, 2019) | |||
4-85570437-T-C | Likely benign (Jun 07, 2020) | |||
4-85570549-A-G | Uncertain significance (Oct 24, 2023) | |||
4-85570561-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
4-85570565-G-A | Likely benign (Dec 09, 2023) | |||
4-85570590-C-T | Uncertain significance (Nov 28, 2023) | |||
4-85570591-G-A | Uncertain significance (Nov 13, 2023) | |||
4-85570657-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
4-85570661-G-A | Uncertain significance (Apr 29, 2019) | |||
4-85570665-G-C | Uncertain significance (Sep 20, 2023) | |||
4-85570705-A-T | not specified | Uncertain significance (Dec 21, 2023) | ||
4-85570706-T-C | ARHGAP24-related disorder | Likely benign (Jan 12, 2023) | ||
4-85570708-A-G | not specified | Conflicting classifications of pathogenicity (Jan 17, 2024) | ||
4-85570719-T-G | Uncertain significance (Aug 10, 2022) | |||
4-85570815-G-A | Benign (Feb 24, 2020) | |||
4-85570865-G-A | Benign (Dec 18, 2019) | |||
4-85570908-A-G | Benign (May 04, 2020) | |||
4-85721665-T-C | Benign (Apr 04, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARHGAP24 | protein_coding | protein_coding | ENST00000395184 | 9 | 527557 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.95e-10 | 0.984 | 125679 | 0 | 69 | 125748 | 0.000274 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.153 | 397 | 406 | 0.979 | 0.0000218 | 5030 |
Missense in Polyphen | 93 | 115.43 | 0.80571 | 1400 | ||
Synonymous | -0.453 | 156 | 149 | 1.05 | 0.00000812 | 1355 |
Loss of Function | 2.35 | 21 | 36.3 | 0.579 | 0.00000236 | 375 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000329 | 0.000329 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000396 | 0.000396 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Rho GTPase-activating protein involved in cell polarity, cell morphology and cytoskeletal organization. Acts as a GTPase activator for the Rac-type GTPase by converting it to an inactive GDP-bound state. Controls actin remodeling by inactivating Rac downstream of Rho leading to suppress leading edge protrusion and promotes cell retraction to achieve cellular polarity. Able to suppress RAC1 and CDC42 activity in vitro. Overexpression induces cell rounding with partial or complete disruption of actin stress fibers and formation of membrane ruffles, lamellipodia, and filopodia. Isoform 2 is a vascular cell-specific GAP involved in modulation of angiogenesis. {ECO:0000269|PubMed:15302923, ECO:0000269|PubMed:15611138, ECO:0000269|PubMed:16862148}.;
- Pathway
- Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases
(Consensus)
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- loftool
- 0.783
- rvis_EVS
- -0.62
- rvis_percentile_EVS
- 17.45
Haploinsufficiency Scores
- pHI
- 0.393
- hipred
- Y
- hipred_score
- 0.540
- ghis
- 0.518
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.486
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arhgap24
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- angiogenesis;signal transduction;cell differentiation;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction
- Cellular component
- cytosol;cytoskeleton;focal adhesion;cell projection
- Molecular function
- GTPase activator activity;protein binding